|
|
| | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate Basic information |
| Product Name: | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate | | Synonyms: | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate;voacamine;12-Methoxy-13-[(3α)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylic acid methyl ester;Voacanginine;MMH 18;NSC 82591;Ibogamine-18-carboxylic acid, 12-methoxy-13-[(3α)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester;methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate USP/EP/BP | | CAS: | 3371-85-5 | | MF: | C43H52N4O5 | | MW: | 704.9 | | EINECS: | 222-151-3 | | Product Categories: | | | Mol File: | 3371-85-5.mol |  |
| | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate Chemical Properties |
| Melting point | 223℃ (dec.) (methanol ) | | alpha | D20 -52° (chloroform) | | density | 1.30±0.1 g/cm3 (20 ºC 760 Torr) | | storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 5 mg/ml | | form | A crystalline solid |
| | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate Usage And Synthesis |
| Uses | Voacamine has shown activity against Leishmania ultrastructure through poisoning the bi-subunit topoisomerase IB. | | Definition | ChEBI: Voacamine is a citraconoyl group. |
| | methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate Preparation Products And Raw materials |
|